SVEDMYR, Sven, Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI, Ondřej LUDKA, Ding ZOU and Ludger GROTE. Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine. Journal of Sleep Research. HOBOKEN: WILEY, 2023, vol. 32, No 4, p. 1-7. ISSN 0962-1105. Available from: https://dx.doi.org/10.1111/jsr.13811.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine
Authors SVEDMYR, Sven (guarantor), Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI, Ondřej LUDKA (203 Czech Republic, belonging to the institution), Ding ZOU and Ludger GROTE.
Edition Journal of Sleep Research, HOBOKEN, WILEY, 2023, 0962-1105.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.400 in 2022
RIV identification code RIV/00216224:14110/23:00130273
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/jsr.13811
UT WoS 000899297400001
Keywords in English antihypertensive treatment; beta-blocker; blood pressure control; diuretic; hypertension; obstructive sleep apnea
Tags 14110228, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 15/11/2023 07:41.
Abstract
We recruited 5,970 patients with hypertension with obstructive sleep apnea (OSA) on current antihypertensive treatment from the European Sleep Apnea Database (ESADA) cohort. The group was subdivided into those receiving monotherapy (n = 3,594) and those receiving dual combined therapy (n = 2,376). We studied how major OSA confounders like age, gender, and body mass index as well as the degree of sleep apnea modified office systolic and diastolic blood pressure. Beta-blockers alone or in combination with a diuretic were compared with other antihypertensive drug classes. Monotherapy with beta-blocker was associated with lower systolic blood pressure, particularly in non-obese middle-aged males with hypertension. Conversely, the combination of a beta-blocker and a diuretic was associated with lower systolic and diastolic blood pressure in patients with hypertension with moderate-severe OSA. Systolic blood pressure was better controlled in female patients using this combined treatment. Our cross-sectional data suggest that specific clinical characteristics and type of antihypertensive medication influence the degree of blood pressure control in patients with hypertension with OSA. Controlled trials are warranted.
PrintDisplayed: 8/10/2024 07:45